Internal Medicine Department, Hôpital Hôtel-Dieu, Centre Hospitalier Universitaire de Nantes, 1 place Alexis Ricordeau, 44093, Nantes, France.
Pneumology Department, Institut du Thorax, Hôpital Guillaume et René Laënnec, Centre Hospitalier Universitaire de Nantes, Nantes, France.
BMC Pulm Med. 2018 May 18;18(1):73. doi: 10.1186/s12890-018-0641-5.
Pleuroparenchymal fibroelastosis (PPFE) is a very rare interstitial lung disease (ILD) characterized by progressive fibrotic lesions of the visceral pleura and the sub-pleural parenchyma, affecting predominantly the upper lobes. PPFE may occur in different contextes like bone marrow or lung transplantations, but also in the context of telomeropathy with mutations of telomerase reverse transcriptase (TERT), telomerase RNA component (TERC) or regulator of telomere elongation helicase 1 (RTEL1) genes. PPFE-like lesions have recently been described in patients with connective tissue disease (CTD)-related ILD. We report here the first detailed case of PPFE associated to systemic sclerosis (SSc) in a woman free of telomeropathy mutations.
A caucasian 46 year old woman was followed for SSc in a limited form with anti-centromere Ab since 1998, and seen in 2008 for a routine visit. Her SSc was stable, and she had no respiratory signs. Pulmonary function tests showed an isolated decreased cTLCO at 55.9% (of predicted value). Cardiac ultrasonography was normal. Thoracic CT-scan showed upper lobes predominant mild and focal pleural and subpleural thickenings, suggestive of PPFE, with a slight worsening at 8 years of follow-up. She remained clinically stable. Biology only found a moderate and stable peripheral thrombocytopenia, and sequencing analysis did not find any mutations in TERT and TERC genes.
ILD is frequent in SSc but isolated PPFE has never been described so far. In our case, PPFE is not related to telomeropathy, has indolent outcome and seems to have good prognosis. PPFE might be an extremely rare form of SSc-related ILD, although a fortuitous association remains possible.
胸膜肺弹力纤维增生症(PPFE)是一种非常罕见的间质性肺疾病(ILD),其特征为内脏胸膜和胸膜下实质的进行性纤维化病变,主要影响上叶。PPFE 可能发生在骨髓或肺移植等不同背景下,也可能发生在端粒酶逆转录酶(TERT)、端粒酶 RNA 成分(TERC)或端粒延伸螺旋酶 1(RTEL1)基因突变的端粒病背景下。最近在结缔组织疾病(CTD)相关 ILD 患者中描述了类似 PPFE 的病变。我们在此报告首例与系统性硬化症(SSc)相关的无端粒病突变的女性患者的详细病例。
一名 46 岁白人女性,1998 年因抗着丝点抗体阳性而被诊断为局限型 SSc,并于 2008 年进行常规随访。她的 SSc 稳定,无呼吸症状。肺功能检查显示孤立性碳氧血红蛋白(cTLCO)降低,为预计值的 55.9%。心脏超声正常。胸部 CT 扫描显示上叶为主的轻度和局灶性胸膜和胸膜下增厚,提示为 PPFE,8 年随访时略有加重。她的临床状况仍然稳定。生物学检查仅发现中度和稳定的血小板减少,测序分析未发现 TERT 和 TERC 基因突变。
ILD 在 SSc 中很常见,但迄今尚未描述孤立性 PPFE。在我们的病例中,PPFE 与端粒病无关,预后良好且病情进展缓慢。PPFE 可能是一种极为罕见的 SSc 相关 ILD 类型,尽管也可能是偶然关联。